Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

Published:2018-10 Issue:4 Volume:69 Page:896-904
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Estes Chris,Anstee Quentin M.,Arias-Loste Maria Teresa,Bantel Heike,Bellentani Stefano,Caballeria Joan,Colombo Massimo,Craxi Antonio,Crespo Javier,Day Christopher P.,Eguchi Yuichiro,Geier Andreas,Kondili Loreta A.,Kroy Daniela C.,Lazarus Jeffrey V.,Loomba Rohit,Manns Michael P.,Marchesini Giulio,Nakajima Atsushi,Negro Francesco,Petta Salvatore,Ratziu Vlad,Romero-Gomez Manuel,Sanyal Arun,Schattenberg Jörn M.,Tacke Frank,Tanaka Junko,Trautwein Christian,Wei Lai,Zeuzem Stefan,Razavi Homie

Publisher

Elsevier BV

Subject

Hepatology

Reference69 articles.

1. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009;Younossi;Hepatology,2015

2. Population-based risk factors and resource utilization for HCC: US perspective;Sanyal;Curr Med Res Opin,2010

3. The global NAFLD epidemic;Loomba;Nat Rev Gastroenterol Hepatol,2013

4. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology;Chalasani;Gastroenterology,2012

5. Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease;Diabetologia,2016

Cited by 1123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baicalin and N-acetylcysteine regulate choline metabolism via TFAM to attenuate cadmium-induced liver fibrosis;Phytomedicine;2024-03

2. From NAFLD to MASLD: When metabolic comorbidity matters;Annals of Hepatology;2024-03

3. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease;The Lancet Gastroenterology & Hepatology;2024-02

4. Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction–Associated Steatotic Liver Disease: Progress But With Challenges;Gastroenterology;2024-02

5. A Predictive Study of Machine Learning and Deep Learning Procedures Over Chronic Disease Datasets;Feb-Mar 2024;2024-02-01